The Administrative Core (AC) will be responsible for managing, coordinating, and supervising all TBRU activities. The TBRU AC will be directed by a Leadership Team that includes the dual Pis of this application (Henry M. Blumberg, MD at Emory and Joel D. Ernst, MD at NYU) and Rafi Ahmed, PhD (Director, Emory Vaccine Center) who will serve as TBRU Scientific Advisor. These 3 AC Program Directors (PDs) have substantial experience and expertise in immunology, clinical/translational research, and scientific program management. They will provide leadership to support scientific investigation into the immunology of latent TB infection and facilitate communication among investigators, research projects and cores to ensure there is translation and back translation between human subjects studies and animal studies that will utilize a non-human primate TB model. The AC includes a Data Management Center (DMC) under the direction of Dr. Lance Waller (Chair, Emory Department of Biostatistics and Bioinformatics) that will be responsible for collection, storage, quality control, and evaluation of all study data and will provide biostatistical and bioinformatics support to TBRU investigators at all of the collaborating sites. The DMC will collaborate with the Aeras on the implementation of an integrated data management system for tracking of TBRU specimens from both human subjects and non-human primates (NHP) across research projects. The AC will provide effective coordination and communication across projects and cores at collaborating institutions;fiscal management and regulatory requirement oversight;and as part of evaluation activities will monitor progress and assess the degree to which TBRU goals are being met. The PDs will receive input from our Internal Advisory Committee and a Steering Committee as well as NIAID and the External Advisory Group;they will implement changes based on progress or lack of progress achieved and based on scientific discoveries which warrant that new strategies be implemented and new pathways pursued. The AC will also facilitate involvement in collaborative research opportunities across the NIAID TBRU network, leveraging our unique resources including clinical sites, a NHP model for TB, and investigators with expertise in TB immunology

Public Health Relevance

Tuberculosis (TB) is an enormous global public health problem but the mechanisms associated with control of TB infection or progression to active TB are poorly understood. The Administrative Core of this TBRU application will be responsible for managing, coordinating, and supervising all TBRU activities that are focused on enhancing our understanding of the immunology of latent TB infection and control of TB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI111211-01
Application #
8726593
Study Section
Special Emphasis Panel (ZAI1-LG-M (M1))
Project Start
Project End
Budget Start
2014-08-11
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$369,186
Indirect Cost
$75,891
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Li, Kelin; Vorkas, Charles K; Chaudhry, Ashutosh et al. (2018) Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU). PLoS One 13:e0191837
Auld, Sara C; Shah, N Sarita; Cohen, Ted et al. (2018) Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis. Respirology :
Nelson, Kristin N; Shah, N Sarita; Mathema, Barun et al. (2018) Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa. J Infect Dis 218:1964-1973
Dhanda, Sandeep Kumar; Karosiene, Edita; Edwards, Lindy et al. (2018) Predicting HLA CD4 Immunogenicity in Human Populations. Front Immunol 9:1369
Ernst, Joel D (2018) Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design. Cell Host Microbe 24:34-42
Auld, Sara C; Shah, N Sarita; Mathema, Barun et al. (2018) Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities. Eur Respir J 52:
Whatney, Wendy E; Gandhi, Neel R; Lindestam Arlehamn, Cecilia S et al. (2018) A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection. J Immunol 200:3008-3019
Scriba, Thomas J; Carpenter, Chelsea; Pro, Sebastian Carrasco et al. (2017) Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med 196:772-781
Arlehamn, Cecilia S Lindestam; Copin, Richard; Leary, Shay et al. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Hum Immunol 78:325-326
Bablishvili, N; Tukvadze, N; Shashkina, E et al. (2017) Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia. Antimicrob Agents Chemother 61:

Showing the most recent 10 out of 15 publications